Bringing the fundamentals into focus…
Back to TG Therapeutics, Inc.
How TG Therapeutics, Inc. stacks up
TGTX · against 552 other Healthcare companies listed in US-listed
Overall
64/ 100
Near the top of its peers.
Ranked #75 of 553 · scores higher than 85% of peers
Bars: peers in each 10-point band of the overall score63 peers with an overall score of 60–69, including TGTX · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around TGTX| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 595M USD | 97 | 96 | 98 | 99 | 0 / 2 | |
| 1 | 261M USD | 97 | 93 | — | 98 | 0 / 2 | |
| 3 | 2.1B USD | 96 | 96 | 99 | 93 | 0 / 2 | |
| 4 | 1.5B USD | 93 | 94 | 91 | 93 | 0 / 2 | |
| 5 | 609M USD | 91 | 95 | 99 | 99 | 0 / 2 | |
| 75 | 5.8B USD | 64 | 93 | 79 | 69 | 2 / 2 | |
| 75 | 155.7B USD | 64 | 47 | 73 | 94 | 1 / 2 | |
| 75 | 10.0B USD | 64 | 90 | 92 | 56 | 2 / 2 | |
| 75 | 11.4B USD | 64 | 46 | 74 | 82 | 1 / 2 | |
| 75 | 9.3B USD | 64 | 55 | 98 | 87 | 2 / 2 | |
| 75 | 10.4B USD | 64 | 96 | 60 | 79 | 2 / 2 | |
| 84 | 1.8B USD | 63 | 89 | 78 | 65 | 2 / 2 | |
| 84 | 285.2B USD | 63 | 66 | 64 | 86 | 1 / 2 | |
| 84 | 7.0B USD | 63 | 47 | 77 | 80 | 1 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score